Glaxosmithkline | Acreedores Comerciales



Trade Creditors Cambio Fecha
AbbVie 2.94B 2.66B 2024-12
Amgen USD 18.03B 15.63B 2025-06
AstraZeneca 23.99B 1.44B 2025-06
Aurora Cannabis CAD 81.29M 51.77M 2025-06
Bausch Health Companies USD 627M 7M 2025-06
Bristol-Myers Squibb USD 5.43B 1.42B 2025-06
Canopy Growth CAD 24.08M 4.84M 2025-06
Corcept Therapeutics USD 23.52M 4.42M 2025-06
Drreddys Laboratories INR 37.46B 1.44B 2025-06
Eli Lilly USD 4.08B 633.7M 2025-06
GlaxoSmithKline 14.82B 329M 2025-06
Glaxosmithkline 13.65B 10.19B 2025-06
J&J USD 9.54B 766M 2025-03
Merck USD 4.04B 261M 2025-06
Novartis USD 4.51B 245M 2025-06
Pacira USD 30.12M 6.95M 2025-06
Perrigo USD 489M 13.3M 2025-06
Pfizer USD 5.17B 74M 2025-06
Prestige Brands USD 22.21M 3.28M 2025-06
Roche Holding 4.35B 828M 2024-12
Sanofi 7.08B 14.54B 2025-06
Supernus Pharmaceuticals USD 8.22M 1.14M 2025-06
Takeda JPY 421.31B 54.23B 2025-06
Teva Pharmaceutical Industries USD 2.5B 208M 2025-06
Zoetis USD 508M 88M 2025-06


Glaxosmithkline Acreedores Comerciales - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Sep 2025.